Agilent Technologies, Inc. (A) scored on five pillars from its reported financial statements, and ranked against 212 Healthcare companies.
Agilent Technologies, Inc. (A) scores 6.7 out of 10 as of , computed from its reported financial statements. That reads as solid quality. The reading rests on predictability, and growth is what holds it back.
Data provided by Twelve Data. Scores are computed by Lemma Analysis from reported financials.
We cannot judge Agilent Technologies, Inc. yet, because fewer than five years had both a return on capital and a cost of capital we could measure. This is not a “no”.
Quantitative signs of a moat, read from the filed statements. This is not a judgement of where it comes from (brand, network effects, switching costs). How Lemma measures a moat →
As of October 19, 2026, Agilent Technologies, Inc. scores 6.7 out of 10 on the Lemma Quality Score, a reading of solid quality. This band covers companies that do several things well but not everything, so the pillar detail below matters more than the headline. Nothing in it comes from the share price or from forecasts: it is Agilent Technologies, Inc.’s own reported numbers, scored pillar by pillar.
Among the 212 Healthcare companies with a published score, that ranks at the 86th percentile, among the stronger quarter of the group. The median across the group is 4.4, and the top quarter begins at 6.0, so Agilent Technologies, Inc. is well above the typical company here.
Profitability scores 6.8 out of 10, which reads as average. The median across 210 Healthcare companies is 2.7, so Agilent Technologies, Inc. is well above its peers on this pillar and ranks at the 84th percentile. An average profitability reading usually means the company earns a fair return without obvious pricing power, so the other pillars decide more of the story.
Solvency scores 8.4 out of 10, which reads as strong. The median across 150 Healthcare companies is 6.5, so Agilent Technologies, Inc. is well above its peers on this pillar and ranks at the 72nd percentile. Strong solvency points to a balance sheet that can carry its debts comfortably, with interest well covered and little pressure from creditors.
Growth scores 3.5 out of 10, which reads as weak. The median across 107 Healthcare companies is 4.9, so Agilent Technologies, Inc. is below its peers on this pillar and ranks at the 36th percentile. Weak growth means revenue and earnings have been flat or shrinking against peers, which can be cyclical or a sign of a market that is maturing.
Efficiency scores 5.9 out of 10, which reads as average. The median across 200 Healthcare companies is 6.0, so Agilent Technologies, Inc. is in line with its peers on this pillar and ranks at the 47th percentile. An average efficiency reading suggests the business turns its assets and earnings into cash at roughly the rate its sector does.
Predictability scores 8.6 out of 10, which reads as strong. The median across 207 Healthcare companies is 3.4, so Agilent Technologies, Inc. is well above its peers on this pillar and ranks at the 98th percentile. High predictability means the company’s results have moved steadily from year to year, which makes the other pillars more trustworthy as a guide.
The gap between Agilent Technologies, Inc.’s best and worst pillar is wide: predictability at 8.6 against growth at 3.5, 5.1 points apart. An average of two readings this different deserves a closer look than the headline number. Leading with predictability suits a steady compounder, even if the other pillars are less striking. Slow growth limits how fast the business can compound, even when everything else is in order.
The pillar with the most room to move the score is growth. If it rose to the median of Healthcare companies, 4.9, Agilent Technologies, Inc.’s overall score would go from 6.7 to about 7.0. The weights add up to 100 points (profitability 25, solvency 20, growth 20, efficiency 15, predictability 20), and Agilent Technologies, Inc. has a reading on every pillar.
For a fair comparison, start with companies of a similar size: the Healthcare companies below are nearest to Agilent Technologies, Inc. by market value, each scored on the same pillars.
How much profit the company generates from its capital and sales.
The company’s ability to service debt and meet its obligations.
How fast revenue, earnings and cash flow are compounding.
How well assets and earnings convert into cash and output.
How stable and consistent results have been over time.
Each metric is scored from 0 to 10 against sector-aware benchmarks, where higher is better. Metrics roll up into five pillars, and the pillars combine into the overall score using the weights shown. Sector-sensitive metrics are judged relative to peers in the same sector.
This score is a systematic, backward-looking read of reported fundamentals. It does not judge valuation, management quality, competitive moat, or future prospects, and can be distorted by one-off items or unusual accounting. Treat it as a starting point, not a recommendation.
Educational only. Not investment advice.
On this reading Agilent Technologies, Inc. scores 6.7 out of 10, which reads as solid quality. Its strongest pillar is predictability, its weakest is growth. Quality is not the same as a good investment: the score says nothing about the price you would pay.
Agilent Technologies, Inc. ranks at the 86th percentile of the 212 Healthcare companies Lemma publishes a score for. The median there is 4.4 and the top quarter starts at 6.0, against Agilent Technologies, Inc.’s 6.7.
Five pillars, each scored from 0 to 10 against sector-aware benchmarks and then weighted into one overall reading: profitability, solvency, growth, efficiency and predictability. Everything comes from reported financials, and nothing comes from price, sentiment or forecasts.
This page last changed on October 19, 2026. The score moves with the financial statements, so the page changes when a new filing moves the reading rather than on a schedule. Live figures for A are in the app.
No. Quality and valuation are separate questions, and a good business at the wrong price is still a bad purchase. Score the business here, then price it with a DCF you control.
Inside Lemma Analysis the same five pillars run on every company we cover, with the metrics behind each one, current fundamentals, a DCF you control and a watchlist that tells you when the price catches up.
Free to start · No credit card